QDVAX
Price
$12.19
Change
-$0.32 (-2.56%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

QDVAX vs RMFCX

Header iconQDVAX vs RMFCX Comparison
Open Charts QDVAX vs RMFCXBanner chart's image
EquityCompass Quality Dividend A
Price$12.19
Change-$0.32 (-2.56%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
QDVAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QDVAX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QDVAX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. QDVAX (43.9M). QDVAX pays higher dividends than RMFCX: QDVAX (3.32) vs RMFCX (1.69). QDVAX was incepted earlier than RMFCX: QDVAX (11 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. QDVAX (22.00). RMFCX has a lower initial minimum investment than QDVAX: RMFCX (250) vs QDVAX (1000). QDVAX annual gain was more profitable for investors over the last year : 15.34 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. QDVAX (12.65).
QDVAXRMFCXQDVAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD13.89411.423122%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets43.9M98.7B0%
Annual Yield % from dividends3.321.69196%
Returns for 1 year15.3412.63121%
Returns for 3 years-3.2814.16-23%
Returns for 5 years12.6540.3931%
Returns for 10 years41.3861.8467%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc